Polyoma BK virus (BKV) is a ubiquitous virus first identified in a renal allograft recipient B.K. More than 90% of adults are BKV seropositive, indicating past exposure. After primary infection, the virus remains dormant in the urinary tract. During immunosuppression, the virus may become reactivated. The link between BKV and haemorrhagic cystitis (HC) was initially made by the identification of papovavirus-like particles in the urine of patients with HC.
1 Later, with enzyme-linked immunosorbent assay and DNA hybridization, an increased incidence of polyoma BK viruria was reported in patients undergoing haematopoietic stem cells transplantation (HSCT) who developed severe HC. 2 The association between BKV and HC was further substantiated in later studies that demonstrated more frequent presence of viral DNA in patients with HC. 3 The BKV genome comprises three regions, the noncoding control region (NCCR) containing the origin of replication, the promoter and enhancer regions; the early structural region encoding the early protein (large and small T-antigens); and the late structural region encoding the agnoprotein and the viral capsid proteins (VP1-3). BKV exhibits genetic variation over the NCCR and can be classified into archetype and rearranged forms.
4 Archetype BKV is characterized by a linear NCCR without tandem repeats, whereas the rearranged form exhibits variable numbers of duplication and deletion in the NCCR. The rearranged form is thought to arise from archetype BKV after primary infection. 5 Both forms have been demonstrated in human urine and circulating leucocytes, 6 but the relative significance of each remains obscure.
Recent studies show that BK viruria is quantitatively and temporally associated with HC, suggesting that BKV may play a pathogenetic role.
7 This may be due to the immunosuppression following HSCT that leads to reactivation of the BKV dormant in the uroepithelium. Alternatively, mutations 8 or rearrangements 9 in the NCCR region have been implicated as viral factors leading to reactivation. Finally, as BKV is also present in circulating leucocytes, 10 transmission of BKV from the donor to the recipient may also be possible. To address these issues, we have prospectively examined the genotype of BKV in eight HSCT patients with severe HC. The BKV in the urine and leucocytes of the patients before HSCT and during HC, and the BKV in the leucocytes of the donors, were genotyped to define if mutations and/or rearrangements in the NCCR, as well as donor-derived BKV, may contribute to the development of HC.
Peripheral blood was collected from donors and recipients before HSCT. The quantification of BKV in the urine of these patients during HC has been reported previously.
7
DNA was extracted from the leucocytes and urine at the time of peak BK viruria (QIAamp DNA Blood Minikit, Qiagen, Basel, Switzerland) and frozen at À201C until analysis. Nested polymerase chain reaction for the BKV NCCR was performed with two pairs of outer (forward 5 0 -GGC CAT TCC TTG CAG TAC AG-3 0 , reverse 5 0 -CCG TCT ACA CTG TCT TCA CCT CTA C-3 0 ) and inner (forward 5 0 -AAT CAG GCT GAT GAC CTA CC-3 0 , reverse 5 0 -GTT CCA GTC CAG GTT TTA CC-3 0 ) primers. The detection limit (sensitivity) of the PCR was estimated to be 1-10 viral copies.
5 All precautions preventing contamination were rigorously adhered to.
7 In particular, sample collection, DNA extraction, and PCR were carried out in three different laboratories. Negative blanks included in each PCR did not give positive results. PCR products were gel purified and sequenced directly with the inner primers bidirectionally (dRhodamine Terminator Cycle Sequencing Kit PE Biosystems, Foster City, CA, USA) with an automated DNA analyzer (ABI Prism 377, PE Biosystems).
The clinical characteristics of the eight patients were shown in Table 1 . All showed cystoscopic features of severe HC. Sequencing of the NCCR showed that except in one case (case 1), the BKV in the urine of patients before and after HSCT was the archetypal (strain WW) ( Table 2) . In case 1, the NCCR of the virus before HSCT showed single base substitutions at positions 52 (A-T), 53 (A-T), 65 (T-C), 180 (T-A), as well as single base insertions at position 179 and deletion at 182. Owing to the small size of the PCR product and the high fidelity of the Taq polymerase used, these were most likely genuine changes instead of PCR artefact. During peak viruria, only strain WW could be found. BKV was detected in circulating leucocytes in five patients before HSCT. Only the archetype BKV (strain WW) was present. Finally, only the archetype was found in the leucocytes of the donors.
This study showed some instructive points in BK viruria after HSCT. Firstly, we showed that only the archetype BKV was demonstrable in the leucocytes of the donors and the recipients before HSCT. The results agree with previous studies 6,10 that have shown only archetype BKV. We are not able to show rearranged BKV in leucocytes as reported by Chatterjee et al.
5 Therefore, genotyping of BKV in the leucocytes at the NCCR has not been useful in defining whether a transmission of BKV from the donor to the recipient occurs during HSCT.
Secondly, we showed that only the archetype was found in the urine of patients before and after HSCT. Priftakis et al 8 reported that point mutations in the NCCR might enhance the promoter activity of the BKV and increase viral virulence, leading to HC. Our observation does not support the proposition that point mutations or rearrangement in the BKV NCCR leads to HC. Instead, it is more likely that rises in BK virus excretion during HSCT result from the increased host permissiveness during immunosuppression, and the uroepithelial damage due to cytotoxic chemo-irradiation. This is supported by previous observations that increased BK viruria is not associated with any increase in BK viraemia, 7 suggesting that BKV reactivation is due to local host tissue factors rather than inherent changes in the virus.
Lastly, in case one, the virus strain in the urine prior to HSCT was genotypically different from that in the circulating leukocytes. Interestingly, this strain was no longer demonstrable during HC after HSCT, as only the archetype BKV (strain WW) was found. Whether this reflected re-infection of the bladder by the BKV in the circulating leucocytes, or a replication advantage of the BKV WW stain during immunosuppression, will have to be investigated by further studies. a Urine collected at the onset of HC rather than the peak viruria. BKV in urine was quantified by real-time polymerase chain reaction, and the point at which the BKV load reached its peak was chosen for BKV genotyping. Engraftment was defined as the first of three consecutive days after HSCT with absolute neutrophil count of greater than 0.5 Â 10 9 /l. Grading of HC: 2 ¼ gross haematuria; 3 ¼ passage of blood clots; 4 ¼ impaired renal function due to urinary tract obstruction. 
